G&E Herbal Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	118.95	102.06	72.4	7.38	-19.88	-14.3	Upgrade
Depreciation & Amortization	10.43	10.38	9.33	9.4	9.33	9.21	Upgrade
Other Amortization	-	-	-	-	0	0	Upgrade
Loss (Gain) From Sale of Assets	0.01	0.01	0.01	0	0.02	0.01	Upgrade
Other Operating Activities	22.27	22.5	17.98	0.71	1.67	-2.51	Upgrade
Change in Accounts Receivable	-3.29	-3.04	-14.19	4.38	1.08	-2.22	Upgrade
Change in Inventory	-5.38	1.2	1.74	-5.69	-2.85	0.14	Upgrade
Change in Accounts Payable	0.16	1.42	-2	2.47	-0.35	0.35	Upgrade
Change in Unearned Revenue	24.7	-10.01	23.39	71.39	0.28	0	Upgrade
Change in Other Net Operating Assets	9.33	10.16	4.82	9.92	1.52	10.09	Upgrade
Operating Cash Flow	177.17	134.68	113.48	99.96	-9.19	0.77	Upgrade
Operating Cash Flow Growth	33.54%	18.68%	13.52%	-	-	-	Upgrade
Capital Expenditures	-5.92	-5.92	-5.52	-2.95	-1.77	-5	Upgrade
Sale (Purchase) of Intangibles	-0.03	-0.08	-	-0.01	-0.22	-1.77	Upgrade
Investment in Securities	-140.61	-83.05	-82.04	5.4	9	15.9	Upgrade
Other Investing Activities	-0.19	-0.19	-0.87	0.07	-	-0.01	Upgrade
Investing Cash Flow	-146.75	-89.24	-88.43	2.51	7.01	9.13	Upgrade
Long-Term Debt Repaid	-	-0.77	-0.12	-	-	-	Upgrade
Net Debt Issued (Repaid)	-0.82	-0.77	-0.12	-	-	-	Upgrade
Common Dividends Paid	-31.76	-31.76	-	-	-	-	Upgrade
Financing Cash Flow	-32.58	-32.54	-0.12	-	-	-	Upgrade
Net Cash Flow	-2.17	12.9	24.94	102.47	-2.18	9.9	Upgrade
Free Cash Flow	171.25	128.76	107.96	97.01	-10.96	-4.23	Upgrade
Free Cash Flow Growth	32.56%	19.26%	11.29%	-	-	-	Upgrade
Free Cash Flow Margin	62.55%	51.70%	59.50%	150.15%	-44.61%	-14.98%	Upgrade
Free Cash Flow Per Share	2.90	2.18	1.83	1.64	-0.19	-0.07	Upgrade
Cash Interest Paid	0.04	0.04	0	-	-	-	Upgrade
Cash Income Tax Paid	0.19	0.15	0.02	-	-	-	Upgrade
Levered Free Cash Flow	122.27	82.35	67.88	93.19	-5.52	-7.17	Upgrade
Unlevered Free Cash Flow	122.3	82.37	67.88	93.19	-5.52	-7.17	Upgrade
Change in Net Working Capital	-32.95	-3.22	-13.64	-83.33	0.64	-0.05	Upgrade

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.